[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
Michael Leithead Maintained (CC) at Hold with Decreased Target to $30 on, Apr 2nd, 2024
- 🞛 This publication is a summary or evaluation of another publication
Michael Leithead of Barclays, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $32 to $30 on, Apr 2nd, 2024.
Michael has made no other calls on CC in the last 4 months.
There is 1 other peer that has a rating on CC. Out of the 1 peers that are also analyzing CC, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- John McNulty of "BMO Capital" Downgraded from Buy to Sell and Decreased Target to $19 on, Friday, March 1st, 2024